RecruitingNCT02777879

Lung Microbiome and Inflammation in Early COPD

Lung Microbiome and Inflammation in Early Chronic Obstructive Pulmonary Disease (COPD)


Sponsor

NYU Langone Health

Enrollment

230 participants

Start Date

May 1, 2014

Study Type

OBSERVATIONAL

Conditions

Summary

This is a cross sectional case controlled study to assess lung microbiome and inflammation in smokers with and without Chronic Obstructive Pulmonary Disease (COPD). Investigators will look at active bacterial metabolic pathways in the lower airways using metagenomic and metabolomic approaches an assess relationships among microbiome, metagenome, metabolome and host immune responses in COPD and controls. Investigators believe COPD cases will have higher prevalence of pneumotype supraglottic predominant taxa (SPT) than matched controls.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the bacteria living in the lungs (the lung microbiome) and how they may drive inflammation in smokers with early-stage COPD — a progressive condition that makes breathing increasingly difficult — to better understand the early development of this disease. **You may be eligible if...** - You have smoked at least 20 pack-years (e.g., a pack a day for 20 years) - You have been diagnosed with early COPD (GOLD stage 1 or 2), meaning mild to moderate airflow limitation - OR you are a smoker with normal breathing test results (as a comparison group) **You may NOT be eligible if...** - You have severe COPD (lung function below 50% of normal) - You have significant heart disease, diabetes, or serious liver or kidney problems - You have a severe blood clotting disorder - You are pregnant - You drink heavily (more than 6 beers or 4 mixed drinks per day) - You have taken antibiotics within the last 2 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBronchoscopy

Flexible bronchoscopy with bronchoalveolar lavage (BAL) and bronchial brushings will be done in a standardized manner. The bronchoscope tip is sequentially wedged in sub-segments where BAL will be performed on a total of two segments of the lung (120 ml in each segment for a total of 360 ml). Two brushes will be done under direct visualization in both segments. Selection of segments to sample will be based on where abnormalities are in imaging.


Locations(1)

New York University School of Medicine

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02777879